Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil Patel

Showing results (131-140 of 161) with videos related to

Pageof 17
Sort By:
Cancers|February 13, 2025
Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell TherapyThomas Eckert, M S Zobaer, Jessie Boulos, et al.
Acta Neuropathologica Communications|October 21, 2018
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfallsRachel Jester, Iya Znoyko, Maria Garnovskaya, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 23, 2024
Phenotypic Clusters and Multimorbidity in Hypermobile Ehlers-Danlos SyndromeTaylor Petrucci, S Jade Barclay, Cortney Gensemer, et al.
Cancer Research Communications|March 25, 2025
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic SimilarityRoy Elias, Thomas Nirschl, Michael Rezaee, et al.
Ophthalmology|May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDEDavid M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Cells|April 13, 2026
Loss of the DCHS1 Intracellular Domain Expands Neurogenic Proliferation and Generates Van Maldergem-like Neurodevelopmental DefectsKathryn Byerly, Cayla Wolfe, Magdalena Brei, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Frontiers in Medicine|November 14, 2024
A randomized control trial evaluating the advice of a physiological-model/digital twin-based decision support system on mechanical ventilation in patients with acute respiratory distress syndromeBrijesh V Patel, Sharon Mumby, Nicholas Johnson, et al.
BMJ Open Ophthalmology|December 19, 2023
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trialSriniVas R Sadda, Mario Bradvica, Attila Vajas, et al.
JAMA Ophthalmology|June 8, 2023
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical TrialSe Joon Woo, Mario Bradvica, Attila Vajas, et al.
Pageof 17

Showing results (131-140 of 161) with videos related to

Sort By:
Pageof 17
Cancers|February 13, 2025
Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell TherapyThomas Eckert, M S Zobaer, Jessie Boulos, et al.
Acta Neuropathologica Communications|October 21, 2018
Expression of renal cell markers and detection of 3p loss links endolymphatic sac tumor to renal cell carcinoma and warrants careful evaluation to avoid diagnostic pitfallsRachel Jester, Iya Znoyko, Maria Garnovskaya, et al.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes|May 23, 2024
Phenotypic Clusters and Multimorbidity in Hypermobile Ehlers-Danlos SyndromeTaylor Petrucci, S Jade Barclay, Cortney Gensemer, et al.
Cancer Research Communications|March 25, 2025
Clear-Cell Renal Cell Carcinoma Molecular Subtypes Differ by African and European Genetic SimilarityRoy Elias, Thomas Nirschl, Michael Rezaee, et al.
Ophthalmology|May 28, 2013
Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDEDavid M Brown, Quan Dong Nguyen, Dennis M Marcus, et al.
Cells|April 13, 2026
Loss of the DCHS1 Intracellular Domain Expands Neurogenic Proliferation and Generates Van Maldergem-like Neurodevelopmental DefectsKathryn Byerly, Cayla Wolfe, Magdalena Brei, et al.
European Urology|December 6, 2025
Dynamics of Tumor-informed Circulating Tumor DNA and Association with Clinical Responses to Enfortumab and Pembrolizumab in Patients with Locally Advanced or Metastatic Urothelial CarcinomaEvangelia Vlachou, Burles Avner Johnson, Max Kates, et al.
Frontiers in Medicine|November 14, 2024
A randomized control trial evaluating the advice of a physiological-model/digital twin-based decision support system on mechanical ventilation in patients with acute respiratory distress syndromeBrijesh V Patel, Sharon Mumby, Nicholas Johnson, et al.
BMJ Open Ophthalmology|December 19, 2023
Biosimilar SB15 versus reference aflibercept in neovascular age-related macular degeneration: 1-year and switching results of a phase 3 clinical trialSriniVas R Sadda, Mario Bradvica, Attila Vajas, et al.
JAMA Ophthalmology|June 8, 2023
Efficacy and Safety of the Aflibercept Biosimilar SB15 in Neovascular Age-Related Macular Degeneration: A Phase 3 Randomized Clinical TrialSe Joon Woo, Mario Bradvica, Attila Vajas, et al.
Pageof 17